Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 11-2005 | 08-2005 | 05-2005 | 02-2005 | 11-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35 | 99 | 1 | 85 | 15 |
| TOTAL | $51 | $125 | $42 | $85 | $15 |
| Non-Current Assets | |||||
| PPE Net | 3 | 3 | 3 | 5 | 6 |
| Intangibles | 2 | 2 | 2 | 0 | 0 |
| Other Non-Current Assets | 1 | 1 | 1 | 1 | 1 |
| TOTAL | $5 | $6 | $5 | $6 | $6 |
| Total Assets | $56 | $131 | $47 | $91 | $21 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 473 | 572 | 511 | 138 | 133 |
| Accounts payable and accrued liabilities | 61 | 76 | 76 | 463 | 75 |
| Accrued Expenses | 96 | 2 | 99 | 83 | 45 |
| TOTAL | $630 | $650 | $807 | $770 | $253 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $630 | $650 | $807 | $770 | $253 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,614 | 8,519 | 8,519 | 8,069 | 8,069 |
| Common Shares | 2,254 | 2,226 | 1,916 | 1,916 | 1,916 |
| Retained earnings | -2,870 | -2,787 | -2,717 | -2,636 | -2,184 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 12 |
| TOTAL | $-574 | $-520 | $-760 | $-679 | $-232 |
| Total Liabilities And Equity | $56 | $131 | $47 | $91 | $21 |